Lakewood-Amedex Biotherapeutics Inc. (LABT) Historical Stock Prices
Lakewood-Amedex Biotherapeutics Inc. (LABT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LABT
CIK: 2079272
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Iosue
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-29 | 2026-09-22 | CURRENT REPORT | 0001213900-26-104177 | View SEC Doc Filr Page |
| EFFECT | 2026-09-24 | — | EFFECT Filing | 9999999995-26-003056 | View SEC Doc Filr Page |
| S-1 | 2026-09-18 | — | REGISTRATION STATEMENT | 0001213900-26-101512 | View SEC Doc Filr Page |
| DRS | 2026-08-24 | — | DRS Filing | 0001213900-26-092773 | View SEC Doc Filr Page |
| 424B3 | 2026-08-17 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-090808 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001174947-26-000808 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-089380 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-10 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-087338 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-10 | 2026-09-22 | PROXY STATEMENT | 0001213900-26-087336 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-06 | — | SCHEDULE 13G Filing | 0001213900-26-086054 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-30 | 2026-07-30 | PRELIMINARY PROXY STATEMENT | 0001213900-26-083353 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-15 | CURRENT REPORT | 0001213900-26-078328 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-23 | — | SCHEDULE 13G Filing | 0001213900-26-070922 | View SEC Doc Filr Page |
| 424B3 | 2026-06-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-070622 | View SEC Doc Filr Page |
| 424B3 | 2026-06-22 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-070620 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-15 | CURRENT REPORT | 0001213900-26-069512 | View SEC Doc Filr Page |
| 424B3 | 2026-05-26 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-061019 | View SEC Doc Filr Page |
| 424B3 | 2026-05-26 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-061018 | View SEC Doc Filr Page |
| 10-Q | 2026-05-22 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-060640 | View SEC Doc Filr Page |
| 424B4 | 2026-05-14 | — | PROSPECTUS | 0001213900-26-056648 | View SEC Doc Filr Page |
| EFFECT | 2026-05-13 | — | EFFECT Filing | 9999999995-26-001622 | View SEC Doc Filr Page |
| CORRESP | 2026-05-12 | — | CORRESP Filing | 0001213900-26-054931 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-08 | — | UPLOAD Filing | 0000000000-26-004726 | View SEC Doc Filr Page |
| 4 | 2026-05-06 | 2026-04-24 | 4 | 0001193125-26-209581 | View SEC Doc Filr Page |
| 3 | 2026-05-06 | 2026-04-24 | 3 | 0001193125-26-209578 | View SEC Doc Filr Page |